Psychosocial outcomes with the Omnipod® 5 Automated Insulin Delivery System in caregivers of very young children with type 1 diabetes.

Autor: MacLeish SA; University Hospitals Cleveland Medical Center, Rainbow Babies and Children's Hospital, Cleveland, Ohio, USA., Hood KK; Department of Pediatrics, Psychiatry, & Behavioral Sciences, Stanford University School of Medicine, Stanford Diabetes Research Center, Stanford, California, USA., Polonsky WH; Behavioral Diabetes Institute, San Diego, California, USA.; University of California San Diego, San Diego, California, USA., Wood JR; University Hospitals Cleveland Medical Center, Rainbow Babies and Children's Hospital, Cleveland, Ohio, USA., Bode BW; Atlanta Diabetes Associates, Atlanta, Georgia, USA., Forlenza GP; Barbara Davis Center for Diabetes, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA., Laffel LM; Joslin Diabetes Center, Harvard Medical School, Boston, Massachusetts, USA., Buckingham BA; Division of Pediatric Endocrinology, Department of Pediatrics, Stanford University, Stanford, California, USA., Criego AB; International Diabetes Center/HealthPartners Institute, Park Nicollet Clinic Pediatric Endocrinology, Minneapolis, Minnesota, USA., Schoelwer MJ; Center for Diabetes Technology, University of Virginia, Charlottesville, Virginia, USA., DeSalvo DJ; Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA., Sherr JL; Department of Pediatrics, Yale University School of Medicine, New Haven, Connecticut, USA., Hansen DW; Department of Pediatrics, SUNY Upstate Medical University, Syracuse, New York, USA., Conroy LR; Insulet Corporation, Acton, Massachusetts, USA., Huyett LM; Insulet Corporation, Acton, Massachusetts, USA., Vienneau TE; Insulet Corporation, Acton, Massachusetts, USA., Ly TT; Insulet Corporation, Acton, Massachusetts, USA.

Publikováno v: Diabetes, obesity & metabolism [Diabetes Obes Metab] 2024 Dec; Vol. 26 (12), pp. 5569-5579. Date of Electronic Publication: 2024 Sep 20.

Safety and Efficacy of the Omnipod 5 Automated Insulin Delivery System in Adults With Type 2 Diabetes: From Injections to Hybrid Closed-Loop Therapy.

Autor: Davis GM; Department of Medicine, Emory University, Atlanta, GA., Peters AL; Keck School of Medicine of the University of Southern California, Los Angeles, CA., Bode BW; Atlanta Diabetes Associates, Atlanta, GA., Carlson AL; International Diabetes Center, Park Nicollet, HealthPartners, Minneapolis, MN., Dumais B; Insulet Corporation, Acton, MA., Vienneau TE; Insulet Corporation, Acton, MA., Huyett LM; Insulet Corporation, Acton, MA., Ly TT; Insulet Corporation, Acton, MA.

Publikováno v: Diabetes care [Diabetes Care] 2023 Apr 01; Vol. 46 (4), pp. 742-750.

How introduction of automated insulin delivery systems may influence psychosocial outcomes in adults with type 1 diabetes: Findings from the first investigation with the Omnipod® 5 System.

Autor: Polonsky WH; Behavioral Diabetes Institute, 5230 Carrol Canyon Road Ste 208, San Diego, CA 92121, United States; University of California San Diego, 9500 Gilman Dr, La Jolla, CA 92093, United States., Hood KK; Department of Pediatrics, Psychiatry & Behavioral Sciences, Stanford Diabetes Research Center, Stanford University School of Medicine, 279 Campus Drive, B300, Stanford, CA 94305, United States., Levy CJ; Icahn School of Medicine at Mount Sinai, 1 Gustave L. Levy Pl, New York, NY 10029, United States., MacLeish SA; University Hospitals Cleveland Medical Center, Rainbow Babies and Children's Hospital, 11100 Euclid Ave, Cleveland, OH 44106, United States., Hirsch IB; Department of Medicine, University of Washington, 750 Republican Street, Building F, Floor 3, Seattle, WA 98109, United States., Brown SA; Division of Endocrinology, Center for Diabetes Technology, University of Virginia, 560 Ray C Hunt Dr, Charlottesville, VA 22903, United States., Bode BW; Atlanta Diabetes Associates, 1800 Howell Mill Rd #450, Atlanta, GA 30318, United States., Carlson AL; International Diabetes Center, Park Nicollet, HealthPartners, 3800 Park Nicollet Blvd, Minneapolis, MN 55415, United States., Shah VN; Barbara Davis Center for Diabetes, University of Colorado Anschutz Medical Campus, 1775 Aurora Ct #A140, Aurora, CO 80045, United States., Weinstock RS; Department of Medicine, SUNY Upstate Medical University, 750 E Adams St, Syracuse, NY 13210, United States., Bhargava A; Iowa Diabetes Research, 1031 Office Park Rd Suite #2, West Des Moines, IA 50265, United States., Jones TC; Department of Research, East Coast Institute for Research at The Jones Center, 265 Sheraton Blvd, Macon, GA 31210, United States., Aleppo G; Feinberg School of Medicine, Northwestern University, 645 N Michigan Ave Ste 530, Chicago, IL 60611, United States., Mehta SN; Joslin Diabetes Center, Harvard Medical School, One Joslin Place, Boston, MA 02215, United States., Laffel LM; Joslin Diabetes Center, Harvard Medical School, One Joslin Place, Boston, MA 02215, United States., Forlenza GP; Barbara Davis Center for Diabetes, University of Colorado Anschutz Medical Campus, 1775 Aurora Ct #A140, Aurora, CO 80045, United States., Sherr JL; Department of Pediatrics, Yale School of Medicine, 333 Cedar St, New Haven, CT 06510, United States., Huyett LM; Insulet Corporation, 100 Nagog Park, Acton, MA 01720, United States., Vienneau TE; Insulet Corporation, 100 Nagog Park, Acton, MA 01720, United States., Ly TT; Insulet Corporation, 100 Nagog Park, Acton, MA 01720, United States. Electronic address: tly@insulet.com.

Publikováno v: Diabetes research and clinical practice [Diabetes Res Clin Pract] 2022 Aug; Vol. 190, pp. 109998. Date of Electronic Publication: 2022 Jul 16.

Clinical Evaluation of a Novel CGM-Informed Bolus Calculator with Automatic Glucose Trend Adjustment.

Autor: Pinsker JE; Sansum Diabetes Research Institute, Santa Barbara, California, USA.; Results of this study were presented in abstract form at the 14th International Conference on Advanced Technologies & Treatments for Diabetes, June 2021., Church MM; Sansum Diabetes Research Institute, Santa Barbara, California, USA.; Results of this study were presented in abstract form at the 14th International Conference on Advanced Technologies & Treatments for Diabetes, June 2021., Brown SA; Division of Endocrinology, Center for Diabetes Technology, University of Virginia, Charlottesville, Virginia, USA.; Results of this study were presented in abstract form at the 14th International Conference on Advanced Technologies & Treatments for Diabetes, June 2021., Voelmle MK; Division of Endocrinology, Center for Diabetes Technology, University of Virginia, Charlottesville, Virginia, USA.; Results of this study were presented in abstract form at the 14th International Conference on Advanced Technologies & Treatments for Diabetes, June 2021., Bode BW; Atlanta Diabetes Associates, Atlanta, Georgia, USA.; Results of this study were presented in abstract form at the 14th International Conference on Advanced Technologies & Treatments for Diabetes, June 2021., Narron B; Atlanta Diabetes Associates, Atlanta, Georgia, USA.; Results of this study were presented in abstract form at the 14th International Conference on Advanced Technologies & Treatments for Diabetes, June 2021., Huyett LM; Insulet Corporation, Acton, Massachusetts, USA.; Results of this study were presented in abstract form at the 14th International Conference on Advanced Technologies & Treatments for Diabetes, June 2021., Lee JB; Insulet Corporation, Acton, Massachusetts, USA.; Results of this study were presented in abstract form at the 14th International Conference on Advanced Technologies & Treatments for Diabetes, June 2021., O'Connor J; Insulet Corporation, Acton, Massachusetts, USA.; Results of this study were presented in abstract form at the 14th International Conference on Advanced Technologies & Treatments for Diabetes, June 2021., Benjamin E; Insulet Corporation, Acton, Massachusetts, USA.; Results of this study were presented in abstract form at the 14th International Conference on Advanced Technologies & Treatments for Diabetes, June 2021., Dumais B; Insulet Corporation, Acton, Massachusetts, USA.; Results of this study were presented in abstract form at the 14th International Conference on Advanced Technologies & Treatments for Diabetes, June 2021., Ly TT; Insulet Corporation, Acton, Massachusetts, USA.; Results of this study were presented in abstract form at the 14th International Conference on Advanced Technologies & Treatments for Diabetes, June 2021.

Publikováno v: Diabetes technology & therapeutics [Diabetes Technol Ther] 2022 Jan; Vol. 24 (1), pp. 18-25. Date of Electronic Publication: 2021 Sep 03.

Improved glycemic control in 3,592 adults with type 2 diabetes mellitus initiating a tubeless insulin management system.

Autor: Carlson AL; International Diabetes Center at Park Nicollet, 3800 Park Nicollet Blvd, Minneapolis, MN 55416, United States., Huyett LM; Insulet Corporation, 100 Nagog Park, Acton, MA 01720, United States., Jantz J; Insulet Corporation, 100 Nagog Park, Acton, MA 01720, United States., Chang A; Insulet Corporation, 100 Nagog Park, Acton, MA 01720, United States., Vienneau T; Insulet Corporation, 100 Nagog Park, Acton, MA 01720, United States., Ly TT; Insulet Corporation, 100 Nagog Park, Acton, MA 01720, United States. Electronic address: tly@insulet.com.

Publikováno v: Diabetes research and clinical practice [Diabetes Res Clin Pract] 2021 Apr; Vol. 174, pp. 108735. Date of Electronic Publication: 2021 Mar 09.